New CEO Robert Bennett to leverage 20-year history in consumer packaged goods to accelerate the brand’s growth Kids. Protein Smoothie, Daily Detox, Energy Protein and Greens & Protein deliver category-leading levels of nutrition in blends featuring organic pea protein and brown rice, organic fruits and veggies and other beneficial nutrients.
Category: Marketing
Avon Canada celebrates International Women’s Day
… Revivre, Breast Cancer Action Nova Scotia, Dr. H. Bliss Murphy Cancer Care Foundation, Fondation Virage, London Health Sciences, Markham Stouffville Hospital Foundation, The Angel Fund, The Ottawa Hospital Foundation, Wings of Hope Breast Cancer …
Trump’s plan to lower drug prices
President Donald Trump tweets that he is working on a new, competetive health system, and backs a plan by Republicans to replace the Obamacare. Fred Katayama reports.
Keeping Abreast charity backing Kickstarter campaign for…
Sue Pringle founder of Mille Lingerie with her new Millie bra designed to be comfortable for women who have undergone breast reconstruction surgery. Picture: REBECCA LEWIS A Norwich charity is backing a fundraising campaign to develop a bra specially designed for women who have undergone breast reconstruction surgery.
TiGenix Receives Positive Feedback from the FDA on Cx601 Global Phase III Trial Protocol
TiGenix NV , an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platform of allogeneic stem cells, announced today that it has received positive feedback from the U.S. Food and Drug Administration on an improved protocol for its global Phase III trial for the treatment of complex perianal fistulas in Crohn’s disease patients.
Correcting and Replacing Biocad: The first ever biosimilar of interferon beta-1a approved in Russia
The Ministry of Health of the Russian Federation has awarded Biocad marketing authorization for its interferon beta-1a biosimilar, a knockoff of Merck’s RebifA that is a key component in treatment of relapsing-remitting multiple sclerosis and included in all international recommendations and protocols. BIOCAD started the development program for interferon beta-1a biosimilar in 2012 and it took almost 5 years to run all the development phases, including pre-clinical/clinical studies and registration.
Oticon raises awareness of how hearing loss treatment can have positive effect on quality of life
Hearing Loss is the number one cause of years lived with disability for people over 70. In Europe, more than 51 million people suffer from hearing loss, and these numbers will only continue to grow. On World Hearing Day, Oticon, an industry leader in advanced audiology and hearing aid technology, raises awareness of how treatment for hearing loss can have a positive effect on quality of life in both everyday and work situations.
APR Applied Pharma Research and DKSH Bring Innovative Migraine and Pain Treatment to Asian Patients
APR Applied Pharma Research s.a. , the Swiss, independent developer of science driven, patent protected healthcare products, is today proud to announce the business partnership with DKSH, the leading Market Expansion Services provider with a focus on Asia. The partnership involves marketing, sales, distribution and logistics for APR’s patented Diclofenac 50 mg powder oral solution for acute migraine treatment and other pain areas, in Malaysia, the Philippines, Myanmar and Vietnam under the DKSH subsidiary Favorex.
Izun Pharmaceuticals Announces Approval of Curasitea Hydrogel Wound Care Product by FDA
… therapeutic products for a number of indications including: oral care, oncology support, wound care, women’s health care, gastrointestinal disease and dermatologic conditions. Izun uses the inherent advantage of the natural botanical sources to …
Highmark Spoofs Patients With So. Many. Questions Marketing Daily a ” 9 minutes ago
It’s a phenomenon that gets worse with every birthday: The average doctor’s visit gets shorter, while patients’ list of health problems gets longer. So Highmark, the fourth-largest Blue Cross Blue Shield-affiliated health insurance provider, is introducing a new ad campaign that pokes gentle fun at the growing list of health worries that follow people as they sail into their Medicare years.
Smoking Tobacco US Consumption, Demand, Sales, Competitor and Forecast 2017 – ” 2022
PUNE, INDIA, March 3, 2017 / EINPresswire.com / — Summary “Smoking Tobacco in the US, 2017” is an analytical report by that provides extensive and highly detailed current and future market trends in the American tobacco market. It covers market size and structure along with per capita and overall consumption.
Hospital installs restrictions after recent spike of flu cases
… cases, according to Debra Graem, the hospital’s infection preventionist. Information on the Virginia Department of Health’s website shows flu is widespread. That means flu outbreaks or increases in lab-confirmed flu cases or incidences of …
Risk & reward: Stopping a cancer drug to see if you’re cured
… long-term treatment,” that eventually it will come back. But Gleevec’s discoverer, Dr. Brian Druker, head of Oregon Health & Science University’s cancer center, sees it differently. Nearly half of his 250 patients would be eligible to try quitting. …
Some with a blood cancer thought incurable forgo the drugs
… are those of us who don’t think you can cure the disease.” But Gleevec’s discoverer, Dr. Brian Druker, head of Oregon Health & Science University’s cancer center, said nearly half his 250 patients are eligible to try quitting. So far, 49 have and 18 …
Melinta Therapeutics and Menarini Group Enter into Commercial and…
Melinta Therapeutics , a privately held company developing novel antibiotics to treat serious bacterial infections, and Menarini Group, an Italian biopharmaceutical group, today announced the signing of a development and commercialization agreement. As part of this agreement, Melinta has granted the Menarini Group exclusive rights to commercialize Delafloxacin , an investigational anionic fluoroquinolone, under their own brands in 68 countries in Europe, Asia-Pacific including China, South Korea, and Australia , and the Commonwealth of Independent States including Russia.
Despite challenges pharma sector to grow and generate high employment: Experts
… industry will continue to grow and the major growth engines will be domestic sales, exports, an ageing population, Health insurance coverage, increases in per capita spending, Medical tourism etc. All these factors combined together put more …
RLA Collective Wins for Digital Marketing/Advertising at the 2017…
… in Chicago. RLA’s award, “Answering a Mom’s Cry for Help,” was for the Colief Infant Digestive Aid brand. As OTC health and wellness specialists, we not only understand how to bring about success in a highly regulated industry, we set very high …
Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments
Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial intelligence-driven biopharmaceutical company, today announced that the two companies have entered into a strategic research collaboration focused on the identification of new drug candidates for glaucoma. Under the agreement, twoXAR will use its proprietary computational drug discovery platform to discover, screen, and prioritize novel drug candidates with potential application in ocular indications, with a specific focus on glaucoma.
FDA Grants de novo Clearance for the Brain Sentinel Monitoring…
Brain Sentinel’s SPEAC System provides the epilepsy community with a new tool for seizure monitoring when EEG is not feasible. The SPEAC System is the first non-EEG, physiological, signal-based seizure monitoring system cleared by the FDA.
Celltrion’s Rituxan biosimilar wins Eur…
South Korea’s Celltrion announced Wednesday that the European Medicines Agency has granted sales approval to Truxima, its biosimilar drug referencing Roche’s blockbuster lymphatic cancer drug Rituxan. Truxima is the first ever Rituxan biosimilar to be approved by the European drug regulator, as well as the first ever Europe-approved biosimilar monoclonal antibody used to target cancer.
Grow your business: Make the most out of your Facebook storefront
… audience is, you can tailor ads and posts that appeal most to them to generate greater ROI and real business results. Health insurance provider PhilCare relied heavily on Facebook to promote their Emergency Care health cards as well as to drive …
Company-funded studies of approved drugs may not catch safety issues
… study, said by email. “Often, patients at greatest risk of harm like the frail elderly or people with several serious health conditions are excluded from the trials, so post-marketing safety studies are very important.” When post-marketing studies …
Twentieth Century Fox apologizes for a inappropriatea a fake newsa campaign
Twentieth Century Fox apologized Thursday for using several fake news sites and made-up stories to promote its new movie, A Cure for Wellness . The controversial promotional campaign was criticized on social media.
China Exclusive: Chinese affordable lung cancer drug hits market
The new gefitinib cancer-treating drug, whose Chinese commercial name is Yiruike, was produced by Qilu Pharmaceutical . Its release ends an almost decade-long monopoly by Iressa, developed by British multinational biopharmaceutical company AstraZeneca and introduced to China in 2005.
Twentieth Century Fox apologizes for a oeinappropriatea a oefake newsa …
Twentieth Century Fox apologized on Thursday for using several fake news sites and made-up stories to promote its new movie, A Cure for Wellness, reports Variety . The controversial campaign was slammed on social media.
Takeda and TiGenix Report New Data Highlighting Maintenance of…
Takeda Pharmaceutical Company Limited and TiGenix NV today announced new data from the Phase 3 ADMIRE-CD clinical trial, which indicated that investigational compound Cx601, a suspension of allogeneic adipose-derived stem cells , maintained long-term remission of treatment refractory complex perianal fistulas in patients with Crohn’s disease over 52 weeks.[1] Results were presented at the 12th Congress of the European Crohn’s and Colitis Organisation .
When Obamacare costs $19,000 before you get the first penny back
… its PPO or any other policy in North Texas. Neither are Cigna, Humana, United Healthcare and others. The only health insurance provider left is Blue Cross, which offers two extremely expensive and, from Brenda’s perspective, unacceptable HMO plans. …
Dress like Ed Sheeran for under A 37k? St Elizabeth Hospice and ‘Young Ed’ can help
Hugo Fairbanks Weston, who played “Young Ed” in Ed Sheeran’s Castle on the Hill video is modelling the singer’s old clothes, which will be auctioned by St Elizabeth Hospice. Picture: ST ELIZABETH HOSPICE The sixth-form student who played a young Ed Sheeran in the video for his Suffolk “love song” has followed in the star’s charitable footsteps – quite literally – by wearing some of his old shoes and clothes.
Cannabis industry opposes call for plain packaging and bans on advertising
… Tobacco Fraud. “They’ve never been able to bring this epidemic close to a conclusion. “What would give you faith that health departments are going to effectively regulate any health problems related to these other drugs?” As the Liberal government …
New Study: EpiCast Report: Human Immunodeficiency Virus (HIV) – Epidemiology Forecast to 2025
Human immunodeficiency virus is a lentivirus that impairs and destructs the CD4 cells of the immune system. This weakens the immune system, leaving an infected individual more susceptible to other illnesses and, over time, impairing the individual’s ability to fight off infections.
Hikma signs Easyhaler deal with Orion
Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Finland’s Orion for its new Easyhaler combination product for the treatment of asthma and chronic obstructive pulmonary disease. Under the terms of the agreement, Hikma has the exclusive rights to register, distribute, market and sell the product in all of its MENA markets, leveraging the company’s local presence, sales and marketing capabilities and regulatory expertise.
‘Morning Glories’ Gets New Marketing Boost
The story Mash shares in “Morning Glories” gives readers the courage to know that it is okay to let go. While dealing with the death of a close family member, Tracey A. Mash was inspired to write ” Morning Glories ” in hope of encouraging others that death is not the final chapter for love.
Teaching Tobacco
… yrockets for top performers! Other channels seek to redefine convenience! The economy enters a new stage. The growing health-and-wellness trend. Fuel demand; oil’s slide; multicultural momentum; and data, data, data!
Visa crackdown puts these rural doctors at risk
… We can’t afford to lose someone with his specialization,” said Cindy Morrison, chief marketing officer for Sanford Health, a non-profit health care system based in Sioux Falls that runs 300 hospitals and clinics in predominantly rural communities. A …
CEL-SCI Corporation Reports First Quarter Fiscal 2017 Financial Results
SCI reported the net income available to common shareholders for the quarter ended December 31, 2016 was $3,536,802 or $0.02 per basic share, versus $2,341,813 or $0.02 per basic share during the quarter ended December 31, 2015. CEL-SCI reported an operating loss of for the quarter ended December 31, 2016 versus an operating loss of for the quarter ended December 31, 2015.
3 Scorching Hot Biotech Stocks — Are They Buys?
Making a 70% return in only three months sounds pretty good. Three biotech stocks have done just that and more.
Opiant Pharmaceuticals, Inc. Announces the Appointment of Dr. Phil…
… of bringing new treatments to the people who need them.” Dr. Skolnick joins Opiant from the National Institute of Health, where he served as Director of the Division of Therapeutics and Medical Consequences, National Institute of Drug Abuse, since …
Kiadis Pharma issues clinical and regulatory progress update on ATIR101a and ATIR201a
… cell transplantation (HSCT) in blood cancer. Following regulatory approval from the national authority in Canada (Health Canada), the Company is pleased to announce the initiation of its randomized, controlled, transatlantic Phase III trial with …
Candace McKenzie pins up an entry on the Shoppers Mall’s Valen-tile mosaic on Wednesday.
The Heart and Stroke Foundation of Canada’s Heart Month efforts are relying heavily on the support of Westman’s business community. February is Heart Month, one of the organization’s biggest fundraiser months, with all proceeds raised going toward medical research and education efforts.
Mike Connly Named Chair, Board of Directors, HealthEast
… He has also served as chief technology officer for United HealthGroup IT, chief information officer for United Health Technologies, chief information officer for The St. Paul Companies, and account manager for Hewlett-Packard. Connly has been a …